Whether or not you can get the new coronary vaccine after bone marrow transplantation depends on the time interval after the completion of the transplantation and the degree of stabilization of the disease, and it is recommended that you consult a hematologist.
Bone marrow transplantation generally refers to hematopoietic stem cell transplantation. If the autologous hematopoietic stem cell transplantation has been completed for more than 3 months, or the allogeneic hematopoietic stem cell transplantation has been completed for more than 6 months, and the levels of neutrophils and lymphocytes have returned to normal, and the primary disease has been stabilized, then it is possible to consider receiving the New Crown vaccine.
If the interval after completion of transplantation is insufficient, such as less than 3 months after autologous hematopoietic stem cell transplantation, less than 6 months after the end of allogeneic hematopoietic stem cell transplantation, or the neutrophil level is less than 1.0 x 10^9/L/, the platelet count is less than 50 x 10^9/L, or there is a graft-versus-host disease, it is recommended that the vaccine should be withheld or withheld for the time being.
After bone marrow transplantation, if you consider the new crown vaccine, it is recommended that you consult a hematologist first. If you meet the conditions for vaccination, you can be vaccinated, but you cannot rule out the risk of affecting the original disease. If any discomfort occurs after vaccination, consult a doctor promptly.